Answers are grounded in this paper and cite their sources.
Findings reveal greater vulnerability in children with ADHD and comorbidities due to stimulant shortages, implying a need for better support systems.
Stimulant shortage is highly prevalent and disrupt treatment continuity in children with ADHD in Turkey. Those with psychiatric comorbidities appear particularly sensitive to medication changes, with our findings formally demonstrating a synergistic interaction that amplifies clinical vulnerability. These results highlight the need for coordinated supply systems and targeted psychosocial support to mitigate the emotional and functional consequences of stimulant unavailability.
No takes yet. Share an insight, caveat, or question.
Acehan et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: